ROBERT C. MCNAIR FOR LEXICON GENETICS INC.

Company

LEXICON PHARMACEUTICALS, INC.

Filed

July 18, 2003

Accession Number

0000950129-03-003659

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →